I start with part of optimization the niosome formulations and study the effects of transfection efficiency and cytotoxicity of carriers which are made part 1 and 2 together
, then, when the formula is right, it will be to assess the carriers who have in various ways. such as size and chare measurement, Transmission electron microscopy (TEM) and gel retardation assay. And now, I'm working in part one and two.
การแปล กรุณารอสักครู่..